IRIS
STROMILLO, MARIA LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.933
EU - Europa 5.077
AS - Asia 773
AF - Africa 14
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 4
Totale 11.816
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.912
GB - Regno Unito 1.777
IE - Irlanda 805
CN - Cina 499
SE - Svezia 439
UA - Ucraina 429
IT - Italia 398
RU - Federazione Russa 351
FR - Francia 326
DE - Germania 245
SG - Singapore 156
FI - Finlandia 124
ES - Italia 52
VN - Vietnam 41
BE - Belgio 34
NL - Olanda 22
CA - Canada 19
TR - Turchia 16
MK - Macedonia 15
CI - Costa d'Avorio 10
CZ - Repubblica Ceca 10
HK - Hong Kong 10
PH - Filippine 9
AU - Australia 7
JP - Giappone 7
GR - Grecia 6
IL - Israele 6
IN - India 6
EU - Europa 5
IR - Iran 5
KR - Corea 5
HU - Ungheria 4
MA - Marocco 4
RS - Serbia 4
AL - Albania 3
AT - Austria 3
BG - Bulgaria 3
CH - Svizzera 3
KZ - Kazakistan 3
MD - Moldavia 3
PL - Polonia 3
AZ - Azerbaigian 2
DK - Danimarca 2
ID - Indonesia 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
PT - Portogallo 2
RO - Romania 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
BR - Brasile 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
IM - Isola di Man 1
IS - Islanda 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
NO - Norvegia 1
PA - Panama 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 11.816
Salva come PNG Salva come JPEG
Città #
Southend 1.639
Fairfield 959
Dublin 799
Ashburn 476
Chandler 469
Woodbridge 468
Menlo Park 439
Houston 377
Wilmington 377
Seattle 358
Jacksonville 354
Cambridge 331
Siena 171
Princeton 165
Ann Arbor 163
Nanjing 117
Singapore 110
Beijing 107
Helsinki 53
Boardman 52
Málaga 51
San Mateo 51
San Diego 46
Dong Ket 40
Nanchang 37
New York 37
Lancaster 35
Shenyang 34
Moscow 29
Florence 24
Brussels 23
Düsseldorf 23
London 23
Tianjin 23
Norwalk 22
Los Angeles 20
Milan 20
Changsha 19
Hebei 19
Jiaxing 18
Kunming 18
Jinan 16
Dearborn 15
Shanghai 14
Fremont 12
Izmir 12
Rome 12
Toronto 11
Abidjan 10
Pisa 10
San Francisco 10
Waanrode 10
Washington 10
Ningbo 9
Kilburn 8
Sacramento 8
Santa Clara 8
Zhengzhou 8
Frankfurt am Main 7
Hangzhou 7
Munich 6
Phoenix 6
Renton 6
Skopje 6
Torino 6
Amsterdam 5
Boston 5
Brno 5
Chicago 5
Lanzhou 5
Redwood City 5
Venezia 5
Belgrade 4
Cedar Knolls 4
Central 4
Falls Church 4
Fuzhou 4
Genoa 4
Hong Kong 4
Parma 4
Saint Petersburg 4
Stockholm 4
Tappahannock 4
Villacidro 4
Bonndorf 3
Brdo 3
Caserta 3
Changchun 3
Chisinau 3
Edinburgh 3
General Trias 3
Gyomro 3
Haikou 3
Hefei 3
Hounslow 3
Lappeenranta 3
Monsummano Terme 3
Monte Porzio Catone 3
Mountain View 3
New Bedfont 3
Totale 8.954
Salva come PNG Salva come JPEG
Nome #
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 227
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures 215
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 207
Mitochondrial dysfunction in hereditary spastic paraparesis with mutations in DDHD1/SPG28 194
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 192
Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis 182
null 182
Long-term assessment of no evidence of disease activity in relapsing-remitting MS 175
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS 175
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study 174
Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities 170
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis 166
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 166
Prognostic biomarkers of IFNb therapy in multiple sclerosis patients 160
Twelve-year monitoring of a patient with megalencephalic leukoencephalopathy with subcortical cysts 159
Cortical lesions in radiologically isolated syndrome. 158
Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI 158
Clinical Course of Two Italian Siblings with Ataxia-Telangiectasia-Like Disorder. 155
Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis 154
Assessing response to interferon-β in a multicenter dataset of patients with MS 152
Right-to-left shunt in CADASIL patients: prevalence and correlation with clinical and MRI findings 150
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 150
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome 149
Scoring treatment response in patients with relapsing multiple sclerosis 149
Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis 149
Automated identification of brain new lesions in multiple sclerosis using subtraction images 147
Increased QT variability in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. 146
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study 146
Pronounced structural and functional damage in early adult pediatric-onset multiple sclerosis with no or minimal clinical disability 146
Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. 145
Brain metabolism changes after therapy with chenodeoxycholic acid in a case of cerebrotendinous xanthomatosis. 145
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). 144
Cognitive reserve and cortical atrophy in multiple sclerosis: A longitudinal study 143
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis 140
Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation 136
Impaired vasoreactivity in mildly disabled CADASIL patients 135
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 134
MR evidence of structural and metabolic changes in brains of patients with Werner’s syndrome. 134
Deep gray matter volume loss drives disability worsening in multiple sclerosis 133
Rapidly progressive neurodegeneration in a case with the 7472insC mutation and the A7472C polymorphism in the mtDNA tRNA ser(UCN) gene. 133
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis 131
Refining response to treatment as defined by the Modified Rio Score 131
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes 131
Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis 130
Prominent brain axonal damage and functional reorganization in "pure" adrenomyeloneuropathy. 129
Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis 129
Leukoencephalopathy as a rare complication of hepatitis C infection. 127
Diffuse structural and metabolic brain changes in Fabry disease 127
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome 127
The Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Scale: A Screening Tool to Select Patients for NOTCH3 Gene Analysis. 127
Cortical functional reorganisation and its relationship with brain structural damage in patients with benign multiple sclerosis 127
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 126
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. 123
Post-stroke depression: Research methodology of a large multicentre observational study (DESTRO) 121
Modelling the distribution of cortical lesions in multiple sclerosis 121
Reduced dynamics of functional connectivity and cognitive impairment in multiple sclerosis 121
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. 120
Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study. 118
null 117
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course 117
Effects of Sapropterin on Endothelium-Dependent Vasodilation in Patients With CADASIL: A Randomized Controlled Trial 113
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study 113
Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis. 110
The dilemma of benign multiple sclerosis: Can we predict the risk of losing the “benign status”? A 12-year follow-up study 110
APOE-{varepsilon}4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis. 109
Retinal nerve fibre layer thickness, lesional load and brain atrophy in patients with cerebral autosomal dominant arteriopathy with subcortical infarct and leucoencephalopathy (CADASIL) 108
Leukoencephalopathy, cerebral calcifications, and parenchimal cysts in two siblings. 108
null 108
null 102
Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalization 101
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 100
A comparison of cognitive performances between multiple sclerosis patients with pediatric- versus adult onset disease 99
Imaging neuronal and axonal degeneration in multiple sclerosis. 98
Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis 95
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study 90
Novel human pathological mutations. Gene symbol: NOTCH3. Disease: CADASIL, exon 2 mutation. 87
Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis 87
Structural and Metabolic Brain Abnormalities in Preclinical Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarct and Leukoencephalopathy 86
Mapping the progressive treatment-related reduction of Active MRI lesions in multiple sclerosis 85
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 85
null 84
Short-Term Combination of Glatiramer Acetate with IV Steroid Treatment Preceding Treatment with GA Alone Is Associated with early Suppression of MRI-disease activity in Patients with Relapsing Remitting Multiple Sclerosis 84
MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis 83
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 80
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 77
Efficacy and safety of intravenous immunoglobulin treatment in refractory Behcet's Disease with different organ involvement: a case series 71
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 67
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course 66
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 64
Longitudinal Assessment of Multiple Sclerosis with the Brain-Age Paradigm 61
Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis 53
Vitamin D levels in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) 48
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 44
Operationalizing mild cognitive impairment criteria in small vessel disease: The VMCI-Tuscany Study 42
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 35
Signs and symptoms of Covid‐19 in patients with multiple sclerosis 31
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 30
Hippocampal and deep gray matter nuclei atrophy is relevant for explaining cognitive impairment in MS: A multicenter study 30
Effect of BDNF Val66Met polymorphism on hippocampal subfields in multiple sclerosis patients 26
Hippocampal atrophy in vascular MCI as biomarker of subclinical memory impairment 23
Totale 11.968
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.492
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.405 0 0 0 0 142 174 216 293 206 191 61 122
2020/20211.952 72 189 39 132 89 175 231 358 178 163 177 149
2021/20221.441 107 148 99 101 110 70 79 50 79 124 205 269
2022/20231.778 111 151 235 225 160 336 51 155 204 67 53 30
2023/20241.202 61 25 110 48 35 331 429 26 6 25 24 82
2024/2025652 71 125 240 148 68 0 0 0 0 0 0 0
Totale 12.050